Teresa Brandt, PhD

Teresa Brandt, PhD has a diverse work experience spanning over several companies and roles. Teresa is currently serving as the VP of Regulatory Affairs at Avidity Biosciences, Inc. which they joined in 2021. Prior to this, they held a position as an ASU Biotechnology Advisory Board Member & Instructor at Arizona State University College of Liberal Arts and Sciences starting in 2018. From 2016 to 2021, they worked as an Executive Director at ACADIA Pharmaceuticals Inc.

Teresa also has extensive experience at Ionis Pharmaceuticals, Inc. where they held the position of Executive Director of Regulatory Affairs and Clinical Development from 2009 to 2016. Prior to this, they worked as a Clinical Scientist from 2007 to 2009. Other notable roles include being a Board Member at Organic Nutrition, Inc. from 2006 to 2012 and serving as a Project Director of Clinical and Regulatory Affairs at Avanir Pharmaceuticals from 2002 to 2007.

Earlier in their career, Teresa was a Post-doctoral Fellow at Johns Hopkins Bloomberg School of Public Health from 2000 to 2001. Teresa also worked as a Laboratory Technician at The Scripps Research Institute from 1993 to 1995 and as a Lab Tech at Hybritech, Inc from 1989 to 1991.

Overall, Teresa Brandt, PhD brings a wealth of experience and expertise in regulatory affairs, clinical development, biotechnology, and academia to their current role as VP of Regulatory Affairs at Avidity Biosciences, Inc.

Teresa Brandt, PhD, completed their education by obtaining a Ph.D. in Molecular and Cellular Biology from Arizona State University, where they studied from 1995 to 2000. Prior to that, from 1991 to 1993, they pursued a Bachelor of Science in Biology at San Diego State University. Additionally, from 1989 to 1991, Teresa attended UC Santa Barbara with a focus on Biology and Spanish language, although they did not specify a degree earned during this period.